Dr. Steven Lobritto, MD

NPI: 1346229960
Total Payments
$63,583
2024 Payments
$22,482
Companies
11
Transactions
98

Payment Breakdown by Category

Consulting$35,645 (56.1%)
Other$16,702 (26.3%)
Travel$7,791 (12.3%)
Food & Beverage$3,434 (5.4%)
Education$11.61 (0.0%)

Payments by Nature

Nature of Payment Amount Transactions Share
Consulting Fee $35,645 10 56.1%
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $13,702 3 21.5%
Travel and Lodging $7,791 27 12.3%
Food and Beverage $3,434 56 5.4%
Honoraria $3,000 1 4.7%
Education $11.61 1 0.0%

Top Paying Companies

Company Total Records Latest Year
Mirum Pharmaceuticals, Inc. $19,323 46 $0 (2024)
Alexion Pharmaceuticals, Inc. $14,549 11 $0 (2023)
Ipsen Biopharmaceuticals, Inc $10,664 13 $0 (2024)
ALBIREO PHARMA, INC. $6,135 3 $0 (2023)
KADMON PHARMACEUTICALS LLC $3,692 2 $0 (2018)
Gilead Sciences, Inc. $3,335 10 $0 (2019)
ORPHALAN INC $3,282 7 $0 (2024)
Mallinckrodt Hospital Products Inc. $2,388 1 $0 (2024)
Kadmon Corporation LLC $183.33 3 $0 (2017)
Takeda Pharmaceuticals U.S.A., Inc. $20.13 1 $0 (2023)

Payment History by Year

Year Amount Transactions Top Company
2024 $22,482 41 Ipsen Biopharmaceuticals, Inc ($10,597)
2023 $20,298 29 Mirum Pharmaceuticals, Inc. ($9,897)
2022 $13,582 12 Alexion Pharmaceuticals, Inc. ($13,544)
2019 $3,335 10 Gilead Sciences, Inc. ($3,335)
2018 $3,703 3 KADMON PHARMACEUTICALS LLC ($3,692)
2017 $183.33 3 Kadmon Corporation LLC ($183.33)

All Payment Transactions

98 individual payment records from CMS Open Payments — Page 1 of 4

Date Company Product Nature Form Amount Type
12/12/2024 ORPHALAN INC CUVRIOR (Drug) Food and Beverage In-kind items and services $19.60 General
Category: Hepatology
12/05/2024 Mirum Pharmaceuticals, Inc. Livmarli (Drug) Food and Beverage In-kind items and services $13.44 General
Category: Alagille syndrome
12/03/2024 Mirum Pharmaceuticals, Inc. Livmarli (Drug) Food and Beverage In-kind items and services $25.95 General
Category: Alagille syndrome
11/20/2024 Mallinckrodt Hospital Products Inc. TERLIVAZ (Drug) Consulting Fee Cash or cash equivalent $2,388.00 General
Category: CRITICAL CARE
11/05/2024 Mirum Pharmaceuticals, Inc. Livmarli (Drug) Food and Beverage In-kind items and services $23.69 General
Category: Alagille syndrome
10/29/2024 Ipsen Biopharmaceuticals, Inc Bylvay (Drug) Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $5,046.00 General
Category: Gastroenterology
10/29/2024 Ipsen Biopharmaceuticals, Inc Bylvay (Drug) Food and Beverage In-kind items and services $145.13 General
Category: Gastroenterology
10/29/2024 Ipsen Biopharmaceuticals, Inc Bylvay (Drug) Travel and Lodging In-kind items and services $57.63 General
Category: Gastroenterology
10/24/2024 ORPHALAN INC CUVRIOR (Drug) Food and Beverage In-kind items and services $25.05 General
Category: Hepatology
09/23/2024 ORPHALAN INC CUVRIOR (Drug) Food and Beverage In-kind items and services $22.36 General
Category: Hepatology
09/10/2024 Mirum Pharmaceuticals, Inc. Livmarli (Drug) Food and Beverage In-kind items and services $23.89 General
Category: Alagille syndrome
09/04/2024 Ipsen Biopharmaceuticals, Inc Bylvay (Drug) Food and Beverage In-kind items and services $19.77 General
Category: Gastroenterology
08/03/2024 Mirum Pharmaceuticals, Inc. Livmarli (Drug) Consulting Fee Cash or cash equivalent $2,600.00 General
Category: Alagille syndrome
08/03/2024 Mirum Pharmaceuticals, Inc. Livmarli (Drug) Travel and Lodging Cash or cash equivalent $250.72 General
Category: Alagille syndrome
08/03/2024 Mirum Pharmaceuticals, Inc. Livmarli (Drug) Travel and Lodging Cash or cash equivalent $149.85 General
Category: Alagille syndrome
08/03/2024 Mirum Pharmaceuticals, Inc. Livmarli (Drug) Food and Beverage Cash or cash equivalent $116.46 General
Category: Alagille syndrome
08/03/2024 Mirum Pharmaceuticals, Inc. Livmarli (Drug) Travel and Lodging Cash or cash equivalent $99.24 General
Category: Alagille syndrome
08/03/2024 Mirum Pharmaceuticals, Inc. Livmarli (Drug) Food and Beverage Cash or cash equivalent $69.64 General
Category: Alagille syndrome
08/03/2024 Mirum Pharmaceuticals, Inc. Livmarli (Drug) Travel and Lodging Cash or cash equivalent $33.62 General
Category: Alagille syndrome
08/02/2024 Mirum Pharmaceuticals, Inc. Livmarli (Drug) Consulting Fee Cash or cash equivalent $2,600.00 General
Category: Alagille syndrome
08/02/2024 Mirum Pharmaceuticals, Inc. Livmarli (Drug) Food and Beverage Cash or cash equivalent $143.48 General
Category: Alagille syndrome
08/02/2024 Mirum Pharmaceuticals, Inc. Livmarli (Drug) Food and Beverage Cash or cash equivalent $118.66 General
Category: Alagille syndrome
08/02/2024 Mirum Pharmaceuticals, Inc. Livmarli (Drug) Travel and Lodging Cash or cash equivalent $28.26 General
Category: Alagille syndrome
07/16/2024 ORPHALAN INC CUVRIOR (Drug) Food and Beverage In-kind items and services $17.61 General
Category: Hepatology
07/11/2024 Ipsen Biopharmaceuticals, Inc Bylvay (Drug) Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $5,046.00 General
Category: Gastroenterology

About Dr. Steven Lobritto, MD

Dr. Steven Lobritto, MD is a Pediatric Transplant Hepatology healthcare provider based in New York, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/12/2006. The National Provider Identifier (NPI) number assigned to this provider is 1346229960.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Steven Lobritto, MD has received a total of $63,583 in payments from pharmaceutical and medical device companies, with $22,482 received in 2024. These payments were reported across 98 transactions from 11 companies. The most common payment nature is "Consulting Fee" ($35,645).

Practice Information

  • Specialty Pediatric Transplant Hepatology
  • Location New York, NY
  • Active Since 01/12/2006
  • Last Updated 02/02/2026
  • Taxonomy Code 2080T0004X
  • Entity Type Individual
  • NPI Number 1346229960

Products in Payments

  • Livmarli (Drug) $19,323
  • Bylvay (Drug) $16,800
  • CUVRIOR (Drug) $3,282
  • TERLIVAZ (Drug) $2,388
  • GATTEX (Drug) $20.13
  • (820) Cholbam (Drug) $11.61

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Pediatric Transplant Hepatology Doctors in New York